Bath & Body Works (NYSE:BBWI) Given New $32.00 Price Target at Barclays

Bath & Body Works (NYSE:BBWIGet Free Report) had its target price dropped by equities researchers at Barclays from $45.00 to $32.00 in a research note issued to investors on Wednesday, Benzinga reports. The firm currently has an “equal weight” rating on the stock. Barclays‘s price target suggests a potential upside of 2.53% from the company’s previous close.

A number of other research firms also recently weighed in on BBWI. BMO Capital Markets increased their target price on Bath & Body Works from $50.00 to $55.00 and gave the company an “outperform” rating in a report on Wednesday, June 5th. Wells Fargo & Company cut their target price on Bath & Body Works from $48.00 to $40.00 and set an “equal weight” rating for the company in a research report on Wednesday, July 24th. Deutsche Bank Aktiengesellschaft raised their price target on Bath & Body Works from $53.00 to $57.00 in a report on Monday, June 3rd. Piper Sandler cut their price target on Bath & Body Works from $47.00 to $39.00 and set a “neutral” rating for the company in a report on Thursday, July 11th. Finally, JPMorgan Chase & Co. upgraded Bath & Body Works from an “underweight” rating to a “neutral” rating and raised their price target for the company from $40.00 to $53.00 in a report on Friday, May 17th. Eight equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. According to data from MarketBeat.com, Bath & Body Works presently has an average rating of “Hold” and an average price target of $46.73.

Check Out Our Latest Stock Analysis on BBWI

Bath & Body Works Stock Down 1.4 %

NYSE:BBWI traded down $0.45 during trading hours on Wednesday, hitting $31.21. 1,426,385 shares of the company traded hands, compared to its average volume of 2,966,622. The firm’s 50-day simple moving average is $40.02 and its 200-day simple moving average is $43.88. Bath & Body Works has a one year low of $27.30 and a one year high of $52.99. The company has a market cap of $6.97 billion, a PE ratio of 8.08, a PEG ratio of 1.16 and a beta of 1.85.

Bath & Body Works (NYSE:BBWIGet Free Report) last issued its quarterly earnings data on Tuesday, June 4th. The company reported $0.38 EPS for the quarter, topping the consensus estimate of $0.33 by $0.05. Bath & Body Works had a negative return on equity of 40.00% and a net margin of 11.92%. The company had revenue of $1.38 billion during the quarter, compared to analyst estimates of $1.37 billion. During the same quarter in the previous year, the firm earned $0.33 earnings per share. Bath & Body Works’s revenue was down .9% on a year-over-year basis. As a group, equities research analysts expect that Bath & Body Works will post 3.29 EPS for the current year.

Institutional Investors Weigh In On Bath & Body Works

Several institutional investors have recently modified their holdings of the company. GAMMA Investing LLC purchased a new stake in Bath & Body Works in the 4th quarter valued at approximately $27,000. First Community Trust NA bought a new position in shares of Bath & Body Works during the second quarter worth about $30,000. EverSource Wealth Advisors LLC lifted its position in shares of Bath & Body Works by 72.0% during the fourth quarter. EverSource Wealth Advisors LLC now owns 805 shares of the company’s stock worth $35,000 after purchasing an additional 337 shares during the last quarter. Turtle Creek Wealth Advisors LLC bought a new position in shares of Bath & Body Works during the fourth quarter worth about $35,000. Finally, EntryPoint Capital LLC lifted its position in shares of Bath & Body Works by 224.0% during the first quarter. EntryPoint Capital LLC now owns 1,471 shares of the company’s stock worth $74,000 after purchasing an additional 1,017 shares during the last quarter. Hedge funds and other institutional investors own 95.14% of the company’s stock.

Bath & Body Works Company Profile

(Get Free Report)

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.

Read More

Analyst Recommendations for Bath & Body Works (NYSE:BBWI)

Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.